Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 5/20 | 0.55 |
| ▸ | PTGER3 | P43115 | 5/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.55 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.55 |
| ▸ | CCNC | P24863 | 1/20 | 0.52 |
| ▸ | CDK8 | P49336 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 7/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.44 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.44 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5902874 | 0.82 | FFAR1 (0.51) | PTGER4PTGER3PTGER1PTGER2CCNC | |
| SCHEMBL31212507 | 0.78 | PTGER4 (0.77) | PTGER4PTGER3PTGER1PTGER2FFAR1 | |
| SCHEMBL1261128 | 0.78 | PTGER4 (0.77) | PTGER4PTGER3PTGER1PTGER2FFAR1 | |
| SCHEMBL4273930 | 0.77 | CYP1A2 (0.47) | PTGER4PTGER3PTGER1PTGER2CCNC | |
| SCHEMBL3840320 | 0.77 | IDO1 (0.50) | PTGER4PTGER3PTGER1PTGER2CCNC | |
| SCHEMBL14430419 | 0.77 | FFAR1 (0.56) | PTGER4PTGER3PTGER1PTGER2CCNC | |
| SCHEMBL5440013 | 0.77 | FFAR4 (0.66) | PTGER4PTGER3PTGER1PTGER2FFAR1 | |
| SCHEMBL3746360 | 0.77 | FFAR4 (0.66) | PTGER4PTGER3PTGER1PTGER2FFAR1 | |
| SCHEMBL8479912 | 0.77 | PTGER4 (0.70) | PTGER4PTGER3PTGER1PTGER2CCNC | |
| SCHEMBL6053663 | 0.77 | PTGER4 (0.81) | PTGER4PTGER3PTGER1PTGER2FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6515142-B2 | Intermediates of aromatic amidine derivatives which have anticoagulation action | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-20020062033-A1 | Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-05-23 | — | — | US | disclosed |
| US-6337405-B1 | MULTISTAGE REACTION OF PYRROLE SUBSTITUTED WITH SULFONATE GROUPS AND HYDROXYPHENYLACETIC ACID | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| US-6252088-B1 | COUPLING A NITRILE CONTAININ NAPHTHALENE COMPOUND WITH A COMPOUND CONTAINING PROPIONIC ACID GROUP | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2001-06-26 | — | — | US | disclosed |
| EP-0936215-A1 | PROCESS FOR PREPARING 2-PHENYL-3-NAPHTHYLPROPIONIC ACID DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020062033-A1 | Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives | PROC, F12, F2 | PTGER4 3009/4885PTGER3 2076/4885PTGER1 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.